Moderna (MRNA) PT Raised to $250 at Jefferies, Expects $21B in Guidance
Tweet Send to a Friend
Jefferies analyst Michael Yee raised the price target on Moderna (NASDAQ: MRNA) to $250.00 (from $170.00) expecting 2021 guidance to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
